SORRENTO THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SRNE and buy or sell other stocks, ETFs, and their options commission-free!About SRNE
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments.
CEOHenry H. Ji, PhD
CEOHenry H. Ji, PhD
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1989
Founded1989
Employees—
Employees—
SRNE Key Statistics
Market cap1.43M
Market cap1.43M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume819.32K
Average volume819.32K
High today$0.003
High today$0.003
Low today$0.0003
Low today$0.0003
Open price$0.0003
Open price$0.0003
Volume252.89K
Volume252.89K
52 Week high$0.0985
52 Week high$0.0985
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
SORRENTO THERAPEUTICS(SRNE) stock is priced at $0.00, giving the company a market capitalization of 1.43M.
On 2026-01-01, SORRENTO THERAPEUTICS(SRNE) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading +766.7% above its intraday low and -13.3% below the session's peak.
Trading volume for SORRENTO THERAPEUTICS(SRNE) stock has reached 252.89K, versus its average volume of 819.32K.
The stock's 52-week range extends from a low of $0.00 to a high of $0.10.
The stock's 52-week range extends from a low of $0.00 to a high of $0.10.
People also own
Based on the portfolios of people who own SRNE. This list is generated using Robinhood data, and it’s not a recommendation.